EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance

Zhiyi Chen, Alex Inague, Kamini Kaushal, Gholamreza Fazeli, Danny Schilling, Thamara N Xavier da Silva, Ancely Ferreira Dos Santos, Tasneem Cheytan, Florencio Porto Freitas, Umut Yildiz, Lucas Gasparello Viviani, Rodrigo Santiago Lima und 25 weitere

Molecular Cell · 2024-12 · 84 (23) · 4645-4659.e9

DOI: 10.1016/j.molcel.2024.10.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2024-12. Verfasst von Zhiyi Chen und 36 weiteren Autor:innen. Beteiligte Einrichtung: Rudolf Virchow Zentrum (RVZ), Center for Integrative and Translational Bioimaging, University of Wuerzburg, 97080 Wuerzburg, Germany. Hauptthemen laut MEDLINE: Ferroptosis, Selenocysteine, Peroxiredoxin VI. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, European Research Council, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selenocysteine (Sec) metabolism is crucial for cellular function and ferroptosis prevention and begins with the uptake of the Sec carrier, selenoprotein P (SELENOP). Following uptake, Sec released from SELENOP is metabolized via selenocysteine lyase (SCLY), producing selenide, a substrate for selenophosphate synthetase 2 (SEPHS2), which provides the essential selenium donor, selenophosphate (H2SePO3-), for the biosynthesis of the Sec-tRNA. Here, we discovered an alternative pathway in Sec metabolism mediated by peroxiredoxin 6 (PRDX6), independent of SCLY. Mechanistically, we demonstrate that PRDX6 can readily react with selenide and interact with SEPHS2, potentially acting as a selenium delivery system. Moreover, we demonstrate the functional significance of this alternative route in human cancer cells, revealing a notable association between elevated expression of PRDX6 and human MYCN-amplified neuroblastoma subtype. Our study sheds light on a previously unrecognized aspect of Sec metabolism and its implications in ferroptosis, offering further possibilities for therapeutic exploitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSelenocysteinePeroxiredoxin VIHumansCell Line, TumorNeuroblastomaHEK293 CellsAnimals

Stichwörter der Autor:innen

cancer metabolismcell deathferroptosisneuroblastomaseleniumselenocysteine metabolism

Substanzen

SelenocysteinePeroxiredoxin VIPRDX6 protein, human

Autor:innen und Institutionen

  • Rudolf Virchow Zentrum (RVZ), Center for Integrative and Translational Bioimaging, University of Wuerzburg, 97080 Wuerzburg, Germany.
  • Rudolf Virchow Zentrum (RVZ), Center for Integrative and Translational Bioimaging, University of Wuerzburg, 97080 Wuerzburg, Germany; Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, 05508000…
  • Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Division of Redox Regulation, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • European Molecular Biology Laboratory, Genome Biology Unit, 69117 Heidelberg, Germany.
  • Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, 05508000 Sao Paulo, Brazil.

Förderung

  • NIDDK NIH HHS
  • European Research Council
  • German Research Foundation
  • German José Carreras Foundation for Leucemia

Zitieren

APA

Chen, Z., Inague, A., Kaushal, K., Fazeli, G., Schilling, D., Xavier da Silva, T. N., Dos Santos, A. F., Cheytan, T., Freitas, F. P., Yildiz, U., Viviani, L. G., Lima, R. S., Pinz, M. P., Medeiros, I., Iijima, T. S., Alegria, T. G. P., Pereira da Silva, R., Diniz, L. R., Weinzweig, S., …, & Friedmann Angeli, J. P. (2024). PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance. Molecular Cell, 84(23), 4645-4659.e9. https://doi.org/10.1016/j.molcel.2024.10.027

Vancouver

Chen Z, Inague A, Kaushal K, Fazeli G, Schilling D, Xavier da Silva TN, et al. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance. Molecular Cell. 2024;84(23):4645-4659.e9. doi:10.1016/j.molcel.2024.10.027

BibTeX
@article{Chen2024,
  author = {Chen, Zhiyi and Inague, Alex and Kaushal, Kamini and Fazeli, Gholamreza and Schilling, Danny and Xavier da Silva, Thamara N and Dos Santos, Ancely Ferreira and Cheytan, Tasneem and Freitas, Florencio Porto and Yildiz, Umut and Viviani, Lucas Gasparello and Lima, Rodrigo Santiago and Pinz, Mikaela Peglow and Medeiros, Isadora and Iijima, Thais Satie and Alegria, Thiago Geronimo Pires and Pereira da Silva, Railmara and Diniz, Larissa Regina and Weinzweig, Simon and Klein-Seetharaman, Judith and Trumpp, Andreas and Mañas, Adriana and Hondal, Robert and Bartenhagen, Christoph and Fischer, Matthias and Shimada, Briana K and Seale, Lucia A and Chillon, Thilo Samson and Fabiano, Marietta and Schomburg, Lutz and Schweizer, Ulrich and Netto, Luis E and Meotti, Flavia C and Dick, Tobias P and Alborzinia, Hamed and Miyamoto, Sayuri and Friedmann Angeli, José Pedro},
  title = {PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance},
  journal = {Molecular Cell},
  year = {2024},
  volume = {84},
  number = {23},
  pages = {4645--4659.e9},
  doi = {10.1016/j.molcel.2024.10.027}
}
Kostenlos starten →